Daxor Corporation - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
DXR Nasdaq 8081 www.daxor.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Daxor Corporation

Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026 - Oct 1st, 2026 6:00 am
Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference - Sep 8th, 2026 3:40 pm
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter - Sep 1st, 2026 6:00 am
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas - Jul 29th, 2026 8:40 pm
Dynamic announces July 2026 cash distributions for Dynamic Active ETFs and ETF Series - Jul 21st, 2026 7:00 am
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas - Jul 7th, 2026 6:00 am
Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor - Jun 2nd, 2026 6:00 am
Dynamic announces May 2026 cash distributions for Dynamic Active ETFs and ETF Series - May 19th, 2026 7:00 am
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis - Apr 28th, 2026 6:00 am
Dynamic announces April 2026 cash distributions for Dynamic Active ETFs and ETF Series - Apr 20th, 2026 7:00 am
Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026 - Mar 10th, 2026 7:00 am
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - Mar 3rd, 2026 6:30 am